Evaluation of the Impact of a Connected Application on the Follow-up of Patients Treated for Glial Lesions Operated

Evaluation of the Impact of a Connected Application on the Follow-up of Patients Treated for Glial Lesions Operated: a Prospective, Randomized Study

This study is to evaluate the efficacy of a mobile app for monitoring the quality of life of patients but also on detection delay of side effects and/or complications linked to the therapeutic management. This allow to adapt their care more quickly, through a prospective randomized study. The impact of this connected monitoring of patients' anxiety will also be evaluated in this study as well as the time taken by the medical team to manage alerts generated by this application.

Inclusion Criteria:

• Male or female over 18 years old without upper age limit.
• Subject operated for a non-recurrent glioma (grade II or III or IV glioma / glioblastoma) according to the WHO classification 2016;
• Subject with a connected support (smartphone,...) to download the connected tracking application.
• Unprotected adult within the meaning of the law
• Subject affiliated to a health insurance scheme
• Subject having signed an informed written consent

Exclusion Criteria:

• Minor subject, pregnant or breastfeeding woman;
• Subject under a measure of legal protection, guardianship or deprived of liberty by judicial or administrative decision;
• Antipsychotic treatment (neuroleptic or lithium)
• Subjects with documented cognitive disorders (Alzheimer, other dementia)
• Subject with a personal medical history of psychiatry
• Subject unable to complete a questionnaire on his own (inability to read French language , severe cognitive disorders)
• Medical contraindication to performing an MRI (pace-maker) or scanner;
• Subject refusing to sign informed consent.